On Wednesday shares of Amedisys Inc. (NASDAQ:AMED) closed at $27.86. Company’s sales growth for last 5 years was -4.10% and EPS growth for next 5 years is recorded as 74.55%. Amedisys, Inc. (NASDAQ:AMED), reported its financial results for the first quarter ended March 31, 2015. After adjusting for the 2015 period, $74.0 million ($44.8 million, net of income tax ) or $1.37 per diluted share and for the 2014 period $16.1 million ($9.9 million, net of income tax) or $0.31 per diluted share for certain items. Net service revenue of $301.6 million compared to $298.7 million in 2014.
MetLife, Inc. (NYSE:MET) in last trading activity moved up 2.54% to close at $52.14. Company weekly performance is 2.14% while its quarterly performance stands at 12.11%. MetLife, Inc. (NYSE:MET) is -7.89% away from its 52 week high. MetLife, Inc. (NYSE:MET) Nepal made the first life insurance claims settlement for the victim of the devastating earthquake that hit Nepal on April 25th 2015. The claim was intimated by telephone to the MetLife office and settled on the same day. The policy-owner deceased after the building collapsed due to the earthquake in Chisapani.
On last trading day Fidelity National Financial, Inc. (NYSE:FNF) decreased -0.93% to close at $37.14. Its volatility for the week is 2.42% while volatility for the month is 1.89%. FNF’s sales growth for past 5 years was 7.80% and its EPS growth for past 5 years was 14.30%. Fidelity National Financial, Inc. (NYSE:FNF) monthly performance is 1.50%. Fidelity National Financial (NYSE:FNF) had its price objective hosited by Barclays from $42.00 to $45.00 in a report released on Friday. Barclays currently has an overweight rating on the stock.
On Wednesday shares of Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) closed at $45.59. Company’s EPS growth for next 5 years is recorded as 15.00%. Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) said in a news release that injections of the drug have been shown in clinical studies to be both safe and effective in reducing fat under the chin.
The Coca-Cola Company (NYSE:KO) in last trading activity fell -0.69% to close at $40.49. Company weekly performance is -1.98% while its quarterly performance stands at -2.61%. The Coca-Cola Company (NYSE:KO) is -9.28% away from its 52 week high. Coca-Cola Company (NYSE:KO) shareholders backed a controversial executive pay package. The 80.4% of votes cast by shareholders were in favor of last year’s compensation package for Chief Executive Muhtar Kent and other senior Coke managers. That was down from 90.9% at Coke last year.